SPARC is ready to spark !! This is monthly chart of SPARC
stock is making Ascending triangle pattern from 2008
Stock has good potential to go up till 420-450 levels in weeks to come
Currently prices are around 230 levels
Thank You !!
−12.59 INR
−3.87 B INR
755.45 M INR
81.61 M
About SUN PHARMA ADV.RES.CO.LTD
Sector
CEO
Anilkumar Raghavan
Headquarters
Mumbai
Website
Founded
2006
ISIN
INE232I01014
FIGI
BBG000R3LTP9
Sun Pharma Advanced Research Co. Ltd. is a bio-pharmaceutical company, which engages in the research and development of pharmaceuticals. It operates through the Within India and Outside India geographical segments. The company was founded on March 1, 2006, and is headquartered in Mumbai, India.
SUN PHARMA ADV-SWING TRADESUN PHARMA ADV-
Nice Head & Shoulder Breakout and Retest.
Stock gave a good Volume spike while breakout.
Retest volume is less than 20MA.
Best buy @ 260
SL @ 240
Target @ 350
SPARC BREAKOUT !!Round Bottom Breakout done.
Good for Short term and Long term.
Target 480 , 600, 750.
Do Like ,Comment , Follow for regular Updates...
Disclaimer : This is not a Buy or Sell recommendation. I am not SEBI Registered. Please consult your financial advisor before making any investments . This is for
After Retesting the breakout zone again raising for new highs340-345 is the breakout zone, after retesting and raising. We can consider for entry above 360 for a target 422.
#SPARC is getting ready for a sparkling move #superchartzKey Levels:
Support: 360 to 350
Resistance: 389, 399, 421
Key Drivers:
Sun Pharma Advanced Research Company Ltd focuses on R&D of pharmaceutical products, earning revenue from license fees, royalties, and R&D services. In FY23, it obtained USFDA approval for Sezaby and filed for NDA of PDP-716
SPARC Buy Setup"Super valid-looking! Leave a comment if you like my entry setup. This share is for educational learning purposes only, and I am not responsible for your profit or loss. Note: For more details, check the chart."
Double bottom formationDouble bottom formation
FLag and pole breakout
MACD turning bullish
Target 450,480
SL 340
Sun Pharma Advanced Research Company Ltd*Sun Pharma Advanced Research Company Ltd*
P&F; Formation on Monthly Basis.
Price BreakOut Needed. To be Watched.
Resistance @ 390.
Vol. BuiltUp Getting Stronger.
RSI: 1H>DM. All in Bullish Zone.
EMAs: Widening Gaps amongst 20 /50 /100 /200.
*Trail SL with Upside*
*Book Profit as per Risk Appetit
Perfect on-neck pattern breakout on daily chartA Bullish Breakout of On Neck pattern and a Rounding Bottom is visible on the Daily chart of NSE:SPARC
MACD gave Positive crossover on Daily, Weekly and Monthly chart. So, expecting the momentum to continue.
One can create a fresh position in the scrip as per the levels mentioned on the chart.
Inverted Head & Shoulder breakoutThe stock has broken a 1.5 yr inverted H&S with 3x weekly volumes. Buy at 273 for a target of 336 in short term. Use a 1:2 risk reward.
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SPARC is 201.29 INR — it has decreased by −1.03% in the past 24 hours. Watch SUN PHARMA ADV.RES.CO.LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange SUN PHARMA ADV.RES.CO.LTD stocks are traded under the ticker SPARC.
SPARC stock has fallen by −13.16% compared to the previous week, the month change is a 4.84% rise, over the last year SUN PHARMA ADV.RES.CO.LTD has showed a −21.95% decrease.
SPARC reached its all-time high on Mar 10, 2015 with the price of 593.85 INR, and its all-time low was 35.16 INR and was reached on Dec 15, 2008. View more price dynamics on SPARC chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SPARC stock is 2.46% volatile and has beta coefficient of 1.05. Track SUN PHARMA ADV.RES.CO.LTD stock price on the chart and check out the list of the most volatile stocks — is SUN PHARMA ADV.RES.CO.LTD there?
Today SUN PHARMA ADV.RES.CO.LTD has the market capitalization of 66.04 B, it has increased by 2.78% over the last week.
Yes, you can track SUN PHARMA ADV.RES.CO.LTD financials in yearly and quarterly reports right on TradingView.
SPARC net income for the last quarter is −1.07 B INR, while the quarter before that showed −959.00 M INR of net income which accounts for −11.92% change. Track more SUN PHARMA ADV.RES.CO.LTD financial stats to get the full picture.
No, SPARC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 603.00 employees. See our rating of the largest employees — is SUN PHARMA ADV.RES.CO.LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SUN PHARMA ADV.RES.CO.LTD EBITDA is −4.05 B INR, and current EBITDA margin is −528.15%. See more stats in SUN PHARMA ADV.RES.CO.LTD financial statements.
Like other stocks, SPARC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SUN PHARMA ADV.RES.CO.LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SUN PHARMA ADV.RES.CO.LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SUN PHARMA ADV.RES.CO.LTD stock shows the sell signal. See more of SUN PHARMA ADV.RES.CO.LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.